tiprankstipranks
Satellos Bioscience (MSLE)
NASDAQ:MSLE
US Market
MSLE
Satellos Bioscience
RESEARCH TOOLSreports
Want to see MSLE full AI Analyst Report?

Satellos Bioscience (MSLE) Income Statement

32 Followers

Satellos Bioscience Income Statement

Last quarter (Q4 2025), Satellos Bioscience's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q4, Satellos Bioscience's net income was C$-7.42M. See Satellos Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Mar 23Mar 22
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -5.09KC$ -20.00KC$ -8.82MC$ -3.73MC$ -119.92K
Operating Expenses
C$ 26.92MC$ 27.79MC$ 15.46MC$ 8.43MC$ 4.70M
Depreciation and Amortization
C$ 5.09KC$ 20.00KC$ 7.00KC$ 337.00KC$ 165.69K
EBITDA
C$ -26.92MC$ -28.08MC$ -15.71MC$ -8.09MC$ -4.60M
Operating Income
C$ -26.92MC$ -27.81MC$ -15.46MC$ -8.43MC$ -4.74M
Other Income/Expenses
C$ 1.79MC$ -291.00KC$ -426.00KC$ -2.89MC$ -8.86M
Pretax Income
C$ -25.13MC$ -28.10MC$ -15.89MC$ -11.32MC$ -15.51M
Net Income
C$ -25.31MC$ -28.10MC$ -15.89MC$ -11.32MC$ -15.51M
Per Share Metrics
Basic EPS
C$ -1.73C$ -2.88C$ -2.16C$ -3.84C$ -7.68
Diluted EPS
C$ -1.73C$ -2.88C$ -2.16C$ -3.84C$ -7.68
Weighted Average Shares Outstanding
 14.60M 9.56M 7.20M 2.97M 2.01M
Weighted Average Shares Outstanding (Diluted)
 14.60M 9.56M 7.20M 2.97M 2.01M
Currency in CAD

Satellos Bioscience Earnings and Revenue History